Apollo Hospitals Group – 40 Academicians and Clinician‑Researchers Recognised in Stanford‑Elsevier Top 2% Global Scientists List 2026
On October 22, 2026, Apollo Hospitals Group issued a press release from New Delhi stating that forty of its academicians and clinician‑researchers have been included in the Stanford University–Elsevier Top 2% Global Scientists List for 2026. The Stanford list identifies the world’s leading researchers by selecting those who rank in the top 2 percentile or are among the top 100,000 scientists by c‑score, calculated with and without self‑citations.
The recognised individuals comprise senior consultants of Apollo Hospitals, faculty members of the Apollo Institute of Medical Sciences and Research (AIMSR), adjunct professors of the Apollo Hospitals Educational & Research Foundation (AHERF), and fourteen editorial board members of Apollo Medicine, the group’s official journal. Their collective work spans multiple specialties and disciplines, influencing clinical practice, healthcare policy, medical education, and patient outcomes.
Dr. Prathap C. Reddy, Founder and Chairman of Apollo Hospitals Group, said the inclusion of forty eminent physicians and surgeons reflects the group’s unwavering commitment to advancing healthcare through research, innovation, education, and clinical excellence. Dr. Preetha Reddy, Executive Vice‑Chairperson of Apollo Hospitals Enterprise Ltd, added that the achievements underscore the integration of cutting‑edge research with compassionate clinical care and will inspire the next generation of healthcare professionals.
The announcement also reiterates Apollo’s scale: the organization operates 76 hospitals with more than 10,400 beds, over 6,600 pharmacies, 264 clinics, 2,182 diagnostic centres, and more than 800 telemedicine centres, making it the world’s largest integrated healthcare platform. Apollo is noted as a leading cardiac centre, having performed over 300,000 angioplasties and 200,000 surgeries to date.
The press release was distributed through PRNewswire, with a disclaimer that PTI assumes no editorial responsibility for the content.